耳鼻咽喉科用医薬品の世界市場レポート 2024年

耳鼻咽喉科用医薬品の市場規模は近年力強く成長しています。2023年の15億8,000万米ドルから2024年には17億1,000万米ドルに、CAGR8.0％で拡大します。実績期間の成長は、耳感染症の流行、薬剤製剤の進歩、償還政策、予防対策に起因しています。

耳鼻咽喉科用医薬品市場規模は、今後数年間で力強い成長が見込まれます。2028年には22億4,000万米ドルに成長し、CAGRは7.0％となります。予測期間の成長は、世界の医療アクセス、研究開発と医薬品開発、電子医療と遠隔診察、患者教育とサポートに起因しています。予測期間の主要動向には、抗菌薬耐性管理、標的治療、個別化耳ケア、革新的ドラッグデリバリーなどがあります。

耳の感染症の急増が、当面の耳鼻咽喉科用医薬品市場の拡大を牽引すると予測されます。医学的に耳炎と呼ばれる耳の感染症は、細菌感染やウイルス感染に起因することが多く、耳に影響を及ぼす炎症性疾患です。耳鼻咽喉科用医薬品は、様々な耳の感染症に悩む人々に、的を絞った治療を提供し、全身への吸収を最小限に抑え、潜在的な合併症を回避する上で重要な役割を果たしています。例えば、2023年4月に世界保健機関（WHO）が発表したデータによると、2050年までに約25億人が難聴に罹患し、少なくとも7億人が聴覚治療を必要としています。その結果、耳の感染症が増加し、耳鼻咽喉科用医薬品市場の成長促進要因となっています。

予測される医療支出の増加は、当面の耳鼻咽喉科用医薬品市場成長の重要な促進要因となります。医療支出には、医療機器、病院や医師によるサービス、処方薬、公衆衛生への取り組みなど、医療関連の商品やサービスに対する金銭的支出の総額が含まれます。医療支出が増えれば、新薬の研究開発に使える財源も増えます。その結果、耳に関連するさまざまな症状に対処するための革新的な耳鼻咽喉科用医薬品が生み出される可能性があります。例えば、米国の連邦機関であるメディケア＆メディケイド・サービスセンターが2022年3月に発表した2021～2030年国民医療費（NHE）報告書では、2021年から2030年にかけて国民医療費が年平均5.1％増加し、2030年には推定6兆8,000億米ドルに達すると予測されています。さらに同期間中、メディケア支出は年率7.2％で拡大し、メディケイド支出は年率5.6％で成長すると予測されています。したがって、医療支出の増加は、耳鼻咽喉科用医薬品市場の成長の原動力となっています。

2023年の耳鼻咽喉科用医薬品市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域と予想されます。耳鼻咽喉科用医薬品レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の耳鼻咽喉科用医薬品市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の耳鼻咽喉科用医薬品市場規模実績と成長、2018～2023年
• 世界の耳鼻咽喉科用医薬品市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の耳鼻咽喉科用医薬品市場、薬剤クラス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• セルメノリティクス
• 耳の麻酔薬
• 耳用抗感染症薬
• 耳用ステロイド
• その他の薬剤クラス
• 世界の耳鼻咽喉科用医薬品市場、適応症別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 中耳炎
• 中耳感染症
• その他の適応症
• 世界の耳鼻咽喉科用医薬品市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 経口
• 局所
• 注射
• その他の投与経路
• 世界の耳鼻咽喉科用医薬品市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 専門クリニック
• 在宅医療
• その他のエンドユーザー

第7章 地域と国の分析

• 世界の耳鼻咽喉科用医薬品市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の耳鼻咽喉科用医薬品市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 耳鼻咽喉科用医薬品市場の競合情勢
• 耳鼻咽喉科用医薬品市場の企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson Limited
  • Merck and Co. Inc.
  • AbbVie Inc.
  • Bayer AG

第31章 その他の主要と革新的な企業

• Novartis AG
• Sanofi SA
• Abbott Laboratories
• AstraZeneca plc
• GlaxoSmithKline Plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Alcon Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

“Otic Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on otic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for otic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The otic drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Cerumenolytics; Otic Anesthetics; Otic Anti-Infectives; Otic Steroids; Other Drug Class
• 2) By Indication: Otitis; Middle Ear Infections; Other Indication
• 3) By Route of Administration: Oral; Topical; Injectable; Other Route of Administration
• 4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; Merck and Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Otic drugs refer to pharmaceutical substances or medications specially formulated for administration through the ear canal. These drugs are tailored to address a range of conditions affecting the ears, including infections, inflammation, pain, and excessive earwax buildup. Their mode of action involves delivering the medication directly to the affected area, enabling targeted treatment and minimizing the risk of systemic side effects.

The primary categories of otic drugs encompass cerumenolytics, otic anesthetics, otic anti-infectives, otic steroids, and other specialized formulations. Cerumenolytics are medications designed to soften and facilitate the removal of earwax from the ear canal. These drugs find application in treating conditions like otitis and middle ear infections, among others. Otic drugs can be administered through various routes including oral, topical, injectable, and others. They are utilized by diverse end-users such as hospitals, specialty clinics, home care providers, and others in the healthcare ecosystem.

The otic drugs market research report is one of a series of new reports from The Business Research Company that provides otic drug market statistics, including otic drugs industry global market size, regional shares, competitors with an otic drugs market share, detailed otic drugs market segments, market trends and opportunities and any further data you may need to thrive in the otic drugs industry. This otic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The otic drugs market size has grown strongly in recent years. It will grow from $1.58 billion in 2023 to $1.71 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to prevalence of ear infections, advancements in drug formulations, reimbursement policies, preventive measures.

The otic drugs market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to global healthcare access, research and drug development, elemedicine and remote consultations, patient education and support. Major trends in the forecast period include antimicrobial resistance management, targeted therapies, personalized ear care, innovative drug delivery.

The surge in the prevalence of ear infections is anticipated to drive the expansion of the otic drugs market in the foreseeable future. Medically referred to as otitis, an ear infection is an inflammatory condition affecting the ear, often stemming from bacterial or viral infections. Otic drugs play a crucial role in providing targeted treatment, minimizing systemic absorption, and averting potential complications for individuals grappling with various ear infections. For instance, data from the World Health Organization (WHO) in April 2023 indicated that by 2050, approximately 2.5 billion people would be affected by hearing loss, with at least 700 million individuals in need of hearing treatment. Consequently, the escalating prevalence of ear infections stands as a significant driver for the growth of the otic drugs market.

The projected increase in healthcare expenditure is set to be a significant driver for the growth of the otic drugs market in the foreseeable future. Healthcare expenditure encompasses the total monetary outlay on healthcare-related goods and services, covering medical equipment, hospital and physician services, prescription drugs, as well as public health initiatives. With a rise in healthcare expenditure, more financial resources become available for the research and development of new drugs. This, in turn, can lead to the creation of innovative otic drugs tailored to address various ear-related conditions. For instance, the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services in March 2022, a federal agency in the US, projected an annual average increase of 5.1% in national health spending between 2021 and 2030, reaching an estimated $6.8 trillion by 2030. Furthermore, during the same period, Medicare expenditures are anticipated to expand at a 7.2% annual rate, while Medicaid spending is expected to grow at a 5.6% yearly rate. Hence, the escalating healthcare expenditure serves as a driving force behind the growth of the otic drugs market.

The scarcity of skilled professionals and inadequate healthcare infrastructure present significant constraints on the growth trajectory of the otic drug market. The deficiency of proficient healthcare workers can create obstacles for patients seeking access to necessary drugs, particularly in developing regions. For instance, as of March 2023, the World Health Organization predicts a projected deficit of 15 million healthcare workers globally by 2030, with the most severe shortages expected in regions like Africa, the Eastern Mediterranean, and the Middle East. Consequently, the insufficiency of skilled professionals and the inadequacies in healthcare infrastructure stand as substantial impediments to the growth of the otic drug market.

Leading companies in the otic drugs market are actively introducing groundbreaking drug-like solutions to maintain their competitive edge. A drug-like cocktail typically comprises a combination of substances or compounds with properties akin to pharmaceutical drugs. These cocktails are commonly formulated for research or experimental purposes, including drug discovery, disease modeling, and studying the impacts of various compounds on biological systems. For instance,in April 2023, Massachusetts Eye and Ear, an internationally renowned center for treatment and research based in the US, unveiled a drug-like cocktail of molecules that successfully regenerated hair cells in a mouse model. This achievement was attained by reprogramming genetic pathways within the inner ear. This breakthrough treatment for hearing loss addresses a critical issue in medicine, where the permanent loss of hair cells is often attributed to aging, noise exposure, and other factors. The approach aims to stimulate the regeneration of sensory cells, ultimately restoring hearing. This development represents a significant step towards a potential gene therapy solution for hearing loss.

In March 2023, Eli Lilly and Company, a prominent US-based pharmaceutical company, completed its acquisition of Akouos Inc. for an approximate sum of $487 million. Through this acquisition, Eli Lilly and Company bolstered its product portfolio in the realm of adeno-associated viral gene therapies, specifically tailored for the treatment of inner ear conditions. This strategic move is aimed at elevating its offerings in otic drug treatments. Akouos Inc., on the other hand, is a precision genetic medicine company based in the US, specializing in the development of otic drugs and gene therapies.

Major players in the otic drugs market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Abbott Laboratories, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited.

North America was the largest region in the otic drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in otic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the otic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The otic drugs market consists of sales of ear drops, solutions, corticosteroids and otic drug suspensions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Otic Drugs Market Characteristics

3. Otic Drugs Market Trends And Strategies

4. Otic Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Otic Drugs Market Size and Growth

• 5.1. Global Otic Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Otic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Otic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Otic Drugs Market Segmentation

• 6.1. Global Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cerumenolytics
• Otic Anesthetics
• Otic Anti-Infectives
• Otic Steroids
• Other Drug Class
• 6.2. Global Otic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Otitis
• Middle Ear Infections
• Other Indication
• 6.3. Global Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Topical
• Injectable
• Other Route of Administration
• 6.4. Global Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users

7. Otic Drugs Market Regional And Country Analysis

• 7.1. Global Otic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Otic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Otic Drugs Market

• 8.1. Asia-Pacific Otic Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Otic Drugs Market

• 9.1. China Otic Drugs Market Overview
• 9.2. China Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Otic Drugs Market

• 10.1. India Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Otic Drugs Market

• 11.1. Japan Otic Drugs Market Overview
• 11.2. Japan Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Otic Drugs Market

• 12.1. Australia Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Otic Drugs Market

• 13.1. Indonesia Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Otic Drugs Market

• 14.1. South Korea Otic Drugs Market Overview
• 14.2. South Korea Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Otic Drugs Market

• 15.1. Western Europe Otic Drugs Market Overview
• 15.2. Western Europe Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Otic Drugs Market

• 16.1. UK Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Otic Drugs Market

• 17.1. Germany Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Otic Drugs Market

• 18.1. France Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Otic Drugs Market

• 19.1. Italy Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Otic Drugs Market

• 20.1. Spain Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Otic Drugs Market

• 21.1. Eastern Europe Otic Drugs Market Overview
• 21.2. Eastern Europe Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Otic Drugs Market

• 22.1. Russia Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Otic Drugs Market

• 23.1. North America Otic Drugs Market Overview
• 23.2. North America Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Otic Drugs Market

• 24.1. USA Otic Drugs Market Overview
• 24.2. USA Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Otic Drugs Market

• 25.1. Canada Otic Drugs Market Overview
• 25.2. Canada Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Otic Drugs Market

• 26.1. South America Otic Drugs Market Overview
• 26.2. South America Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Otic Drugs Market

• 27.1. Brazil Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Otic Drugs Market

• 28.1. Middle East Otic Drugs Market Overview
• 28.2. Middle East Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Otic Drugs Market

• 29.1. Africa Otic Drugs Market Overview
• 29.2. Africa Otic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Otic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Otic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Otic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Otic Drugs Market Competitive Landscape
• 30.2. Otic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck and Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Otic Drugs Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi SA
• 31.3. Abbott Laboratories
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline Plc
• 31.6. Eli Lilly and Company
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan N.V.
• 31.10. Alcon Inc.
• 31.11. Bausch Health Companies Inc.
• 31.12. Sun Pharmaceutical Industries Ltd.
• 31.13. Perrigo Company PLC
• 31.14. Dr. Reddy's Laboratories Ltd.
• 31.15. Aurobindo Pharma Limited

32. Global Otic Drugs Market Competitive Benchmarking

33. Global Otic Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Otic Drugs Market

35. Otic Drugs Market Future Outlook and Potential Analysis

• 35.1 Otic Drugs Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Otic Drugs Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Otic Drugs Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer